Cell Reports (Aug 2021)

GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK

  • David Aguilar-Recarte,
  • Emma Barroso,
  • Anna Gumà,
  • Javier Pizarro-Delgado,
  • Lucía Peña,
  • Maria Ruart,
  • Xavier Palomer,
  • Walter Wahli,
  • Manuel Vázquez-Carrera

Journal volume & issue
Vol. 36, no. 6
p. 109501

Abstract

Read online

Summary: Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) activates AMP-activated protein kinase (AMPK) and plays a crucial role in glucose and lipid metabolism. Here, we examine whether PPARβ/δ activation effects depend on growth differentiation factor 15 (GDF15), a stress response cytokine that regulates energy metabolism. Pharmacological PPARβ/δ activation increases GDF15 levels and ameliorates glucose intolerance, fatty acid oxidation, endoplasmic reticulum stress, and inflammation, and activates AMPK in HFD-fed mice, whereas these effects are abrogated by the injection of a GDF15 neutralizing antibody and in Gdf15−/− mice. The AMPK-p53 pathway is involved in the PPARβ/δ-mediated increase in GDF15, which in turn activates again AMPK. Consistently, Gdf15−/− mice show reduced AMPK activation in skeletal muscle, whereas GDF15 administration results in AMPK activation in this organ. Collectively, these data reveal a mechanism by which PPARβ/δ activation increases GDF15 levels via AMPK and p53, which in turn mediates the metabolic effects of PPARβ/δ by sustaining AMPK activation.

Keywords